Related Experiment Video
Updated: Jun 17, 2025

Author Spotlight: Investigating Bacteriophage-Induced Immune Responses in Gnotobiotic Mice
Published on: January 26, 2024
An enterococcal phage protein inhibits type IV restriction enzymes involved in antiphage defense
Nathan P Bullen1,2, Cydney N Johnson3, Shelby E Andersen3
1Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, ON, L8S 4L8, Canada.
Abstract:
The prevalence of multidrug resistant (MDR) bacterial infections continues to rise as the development of antibiotics needed to combat these infections remains stagnant. MDR enterococci are a major contributor to this crisis. A potential therapeutic approach for combating MDR enterococci is bacteriophage (phage) therapy, which uses lytic viruses to infect and kill pathogenic bacteria. While phages that lyse some strains of MDR enterococci have been identified, other strains display high levels of resistance and the mechanisms underlying this resistance are poorly defined. Here, we use a CRISPR interference (CRISPRi) screen to identify a genetic locus found on a mobilizable plasmid from Enterococcus faecalis involved in phage resistance. This locus encodes a putative serine recombinase followed by a Type IV restriction enzyme (TIV-RE) that we show restricts the replication of phage phi47 in vancomycin-resistant E. faecalis. We further find that phi47 evolves to overcome restriction by acquiring a missense mutation in a TIV-RE inhibitor protein. We show that this inhibitor, termed type IV restriction inhibiting factor A (tifA), binds and inactivates diverse TIV-REs. Overall, our findings advance our understanding of phage defense in drug-resistant E. faecalis and provide mechanistic insight into how phages evolve to overcome antiphage defense systems.
Insights
Multidrug-resistant bacteria pose a growing threat. Researchers identified a new phage resistance mechanism in Enterococcus faecalis and discovered a phage inhibitor protein that overcomes this defense.
Area of Science:
- Microbiology
- Genetics
- Molecular Biology
Background:
- The rise of multidrug-resistant (MDR) bacterial infections, particularly MDR enterococci, is a critical global health concern.
- Bacteriophage (phage) therapy offers a promising alternative to antibiotics, but bacterial resistance to phages is a significant challenge.
- Understanding the genetic basis of phage resistance in MDR bacteria is crucial for developing effective phage therapies.
Purpose of the Study:
- To identify genetic factors conferring phage resistance in *Enterococcus faecalis*.
- To elucidate the mechanism by which phages overcome bacterial resistance.
- To characterize a novel phage-inhibitor protein.
Main Methods:
- Utilized CRISPR interference (CRISPRi) screening to identify phage resistance genes in *Enterococcus faecalis*.
- Employed genetic and biochemical assays to characterize the function of a identified genetic locus and a restriction enzyme.
- Investigated phage evolution and the mechanism of a phage-encoded inhibitor protein.
Main Results:
- Identified a plasmid-borne locus in *Enterococcus faecalis* encoding a Type IV restriction enzyme (TIV-RE) that confers resistance to phage phi47.
- Demonstrated that phage phi47 evolves to overcome TIV-RE restriction through mutations in a specific inhibitor protein.
- Characterized the inhibitor, named type IV restriction inhibiting factor A (tifA), which binds and neutralizes diverse TIV-REs.
Conclusions:
- Discovered a novel phage resistance mechanism mediated by a TIV-RE encoded on a mobilizable plasmid in *Enterococcus faecalis*.
- Provided mechanistic insights into phage adaptation, highlighting the evolution of inhibitor proteins to overcome bacterial antiphage systems.
- Advanced the understanding of phage-bacterial interactions in the context of multidrug-resistant pathogens.
Related Concept Videos
Lysogenic Cycle of Bacteriophages
CRISPR and crRNAs
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
Lytic Cycle of Bacteriophages
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Restriction Enzymes
The host bacteria protect their own genomic DNA from these enzymes by methylating these sites. Some...
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...

